Cannabist Company Holdings Inc - Asset Resilience Ratio
Cannabist Company Holdings Inc (CBST) has an Asset Resilience Ratio of 0.20% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check strategic asset allocation of Cannabist Company Holdings Inc to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2020–2023)
This chart shows how Cannabist Company Holdings Inc's Asset Resilience Ratio has changed over time. See Cannabist Company Holdings Inc balance sheet quality to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Cannabist Company Holdings Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see CBST company net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CA$0.00 | 0% |
| Short-term Investments | CA$1.52 Million | 0.2% |
| Total Liquid Assets | CA$1.52 Million | 0.20% |
Asset Resilience Insights
- Limited Liquidity: Cannabist Company Holdings Inc maintains only 0.20% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Cannabist Company Holdings Inc Industry Peers by Asset Resilience Ratio
Compare Cannabist Company Holdings Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Tonghua Dongbao Pharmaceutical Co Ltd
SHG:600867 |
Drug Manufacturers - Specialty & Generic | 0.76% |
|
Eris Lifesciences Limited
NSE:ERIS |
Drug Manufacturers - Specialty & Generic | 0.58% |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267 |
Drug Manufacturers - Specialty & Generic | 0.01% |
|
Lotus Pharmaceutical Co Ltd
TW:1795 |
Drug Manufacturers - Specialty & Generic | 0.49% |
|
Tasly Pharmaceutical Group Co Ltd
SHG:600535 |
Drug Manufacturers - Specialty & Generic | 11.69% |
|
Changzhou Qianhong Biopharma Co Ltd
SHE:002550 |
Drug Manufacturers - Specialty & Generic | 18.70% |
|
Renhe Pharmacy Co Ltd
SHE:000650 |
Drug Manufacturers - Specialty & Generic | 37.54% |
|
Sun Pharma Advanced Research Company Limited
NSE:SPARC |
Drug Manufacturers - Specialty & Generic | 0.64% |
Annual Asset Resilience Ratio for Cannabist Company Holdings Inc (2020–2023)
The table below shows the annual Asset Resilience Ratio data for Cannabist Company Holdings Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | 0.14% | CA$1.15 Million ≈ $830.45K |
CA$823.11 Million ≈ $595.43 Million |
-0.04pp |
| 2022-12-31 | 0.18% | CA$1.81 Million ≈ $1.31 Million |
CA$994.28 Million ≈ $719.24 Million |
-0.32pp |
| 2021-12-31 | 0.51% | CA$6.96 Million ≈ $5.03 Million |
CA$1.37 Billion ≈ $994.40 Million |
+0.30pp |
| 2020-12-31 | 0.21% | CA$1.51 Million ≈ $1.09 Million |
CA$727.53 Million ≈ $526.28 Million |
-- |
About Cannabist Company Holdings Inc
The Cannabist Company Holdings Inc. cultivates, manufactures, and sells cannabis products and related services for the medical and adult-use markets in the United States and internationally. The company operates medical and/or adult use marijuana businesses and dispensaries. It also offers flowers, concentrates, edibles, oils and tablets, and accessories under the dreamt, Seed & Strain, Triple Se… Read more